All In Biotech

Drug Trial Radar · NCT06156566

European Trial Into Mpox Infection

European Randomised Clinical Trial on mPOX Infection

Last checked: Nov 19, 2026Latest source record: Mar 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

150

Planned (sponsor's estimate)

Start

Aug 9, 2024

Primary completion

Dec 2025

Study completion Aug 2026

Sponsor

Lead sponsor
Miquel EkkelenkampAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
European Clinical Research Alliance for Infectious Diseases (ECRAID); Erasmus Medical Center; Hospital Universitario La Paz; ANRS, Emerging Infectious Diseases; Universiteit Antwerpen
First posted
Dec 5, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this randomized controlled double-blind clinical trial is to test the drug tecovirimat in patients with mpox (previously known as monkeypox) disease. The main questions it aims to answer are: * Is tecovirimat effective in treating mpox infection. * Is tecovirimat safe to treat patients with mpox infection. Participants will receive either the drug tecovirimat orally, 600 mg twice per day, or a matching placebo. The outcome of the infection and the side effect experienced will be compared between the two groups.

Conditions

  • Monkeypox

Interventions

  • Tecovirimat Oral CapsuleDrug

    600 mg, twice daily, 14 days.

  • PlaceboDrug

    3 capsules, twice daily, 14 days.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to complete mpox lesion resolutionTime frame: 28 days

Locations

12 sites in 8 countries. Site status is shown where the registry gives one.

  • Cliniques Universitaires St. Luc

    Brussels, Belgium · Not yet recruiting

  • Institute of Tropical Medicine

    Antwerp, Antwerp, Belgium · Recruiting

  • APHP St. Louis

    Paris, France · Not yet recruiting

  • Universitätsklinikum Bonn

    Bonn, Germany · Not yet recruiting

  • Hospital Luigi Sacco

    Milan, Italy · Not yet recruiting

  • Azienda Ospedaliera Universitaria Integrata Verona - AOUI Verona

    Verona, Italy · Not yet recruiting

  • Amsterdam UMC - AMC

    Amsterdam, Netherlands · Not yet recruiting

  • Oslo Unversity Hospital

    Oslo, Norway · Not yet recruiting

  • Hospital de Santo António dos Capuchos

    Lisbon, Portugal · Not yet recruiting

  • Hospital Clinico San Carlos

    Madrid, Spain · Not yet recruiting

  • Hospital Universitario La Paz

    Madrid, Spain · Not yet recruiting

  • Hospital Universitario Virgen Macarena

    Seville, Spain · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.